FdaApplication

BLA 761156

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNovo Nordisk Inc.
application_typeBLA
approval_date2020-08-28

Products (3)

ProductActive ingredientStrengthDosage form
SOGROYASOMAPACITAN-BECO10MG/1.5ML (6.7MG/ML)Injection
SOGROYA—5MG/1.5ML (3.3MG/ML)Injection
SOGROYA—15MG/1.5ML (10MG/ML)Injection

3 products